TRIM33 loss reduces Androgen Receptor transcriptional output and H2BK120 ubiquitination
Nils EickhoffiD, Janina JanetzkoiD, Nuno PadrãoiD, Sebastian GregoricchioiD, Joseph C. SiefertiD, Liesbeth HoekmaniD, Simon LinderiD, Onno B. BleijerveldiD, Andries Marinus BergmaniD, Wilbert T. ZwartiD
Abstract
The Androgen Receptor (AR) is a ligand-dependent transcription factor that drives prostate cancer development and progression. Although, a detailed effect on AR biology has been described for a number of interacting proteins, many AR coregulators remain to be characterized in relation to their distinct impact on AR function. Here, we describe TRIM33 as a conserved AR-interactor across multiple prostate cancer cell lines. We observed that TRIM33 and AR share overall chromatin interaction profiles, in which TRIM33 is involved in downstream responsive transcriptomic output. In contrast to prior reports, we show that TRIM33 does not impact AR protein stability, but instead propose a model in which TRIM33 facilitates maximal AR activity by interfering with H2BK120 ubiquitination levels.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- FWCI
- 1.96
- Field percentile
- top 14%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/BRD4 complex assembly at enhancers
Viacheslav M. Morozov, Alberto Riva, … Alexander M. Ishov·Nucleic Acids ResearchPeer-reviewed·Aug 15, 2023
- p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer
Jie Luo, Zhixiang Chen, … Arul M. Chinnaiyan·Nature GeneticsPeer-reviewed·Oct 1, 2025
- ABI1 regulates transcriptional activity of Androgen Receptor by novel DNA and AR binding mechanism
B. A. Porter, X. Li, … L. Kotula·bioRxiv·May 26, 2023
- A non-enzymatic role for METTL3 as an Androgen Receptor co-regulator that promotes prostate cancer proliferation.
Raymond J. Kostlan, John T. Phoenix, … Steven Kregel·bioRxiv·Jul 9, 2026
- TRIM24 Degradation Counteracts Adaptation to Androgen Receptor Inhibition in Prostate Cancer
Daniela Bossi, Arianna Vallerga, … Jean-Philippe Paul. Theurillat·bioRxiv·Aug 21, 2025
- Thyroid Hormone Receptor Beta Signaling is a Targetable Driver of Prostate Cancer Growth
Aleksandra Fesiuk, Daniel Pölöske, … Lukas Kenner·Molecular CancerPeer-reviewed·Oct 14, 2025